Robert Hill
Amministratore Delegato presso TAE Life Sciences LLC
Profilo
Robert W.
Hill is currently the Chief Executive & Operating Officer at TAE Life Sciences LLC.
Previously, he held the position of Vice President-Engineering at North American Scientific, Inc. and Senior Vice President-Corporate Development at Accuray, Inc. from 2017 to 2018.
He obtained his undergraduate degree from Carnegie Mellon University.
Posizioni attive di Robert Hill
Società | Posizione | Inizio |
---|---|---|
TAE Life Sciences LLC
TAE Life Sciences LLC Pharmaceuticals: MajorHealth Technology TAE Life Sciences LLC is a privately-held biotechnology company that is developing a new biologically-targeted radiation therapy based on boron neutron capture therapy (BNCT). The company is based in Foothill Ranch, CA. The company is committed to developing next-generation targeted boron drugs and a low-energy accelerator-based neutron source that can treat patients with the most aggressive and recurrent cancers. TAE Life Sciences' Alphabeam™ neutron system and targeted boron drugs are currently in development and have not been approved for sale. Robert W. Hill has been the CEO of the company since 2019. | Amministratore Delegato | 25/07/2023 |
Precedenti posizioni note di Robert Hill
Società | Posizione | Fine |
---|---|---|
ACCURAY INCORPORATED | Direttore Tecnico/Scientifico/R&S | 01/11/2017 |
North American Scientific, Inc.
North American Scientific, Inc. Electronic Equipment/InstrumentsElectronic Technology North American Scientific, Inc. manufactures and markets medical devices for the radiation oncology community. It offers intensity modulated and image guided radiation therapy products and services, as well as brachytherapy seeds used in the treatment of prostate cancer. The company also offers iodine-based and palladium-based implantable brachytherapy seeds for the treatment of prostate cancer. It provides a line of brachytherapy seeds for use in the treatment of ocular melanoma and other solid tumor applications. The company manufactures other radio isotopic products used in various medical, environmental, research and industrial applications. North American Scientific was incorporated in 1990 and is headquartered in Chatsworth, CA. | Corporate Officer/Principal | - |
Formazione di Robert Hill
Carnegie Mellon University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
ACCURAY INCORPORATED | Health Technology |
Aziende private | 2 |
---|---|
North American Scientific, Inc.
North American Scientific, Inc. Electronic Equipment/InstrumentsElectronic Technology North American Scientific, Inc. manufactures and markets medical devices for the radiation oncology community. It offers intensity modulated and image guided radiation therapy products and services, as well as brachytherapy seeds used in the treatment of prostate cancer. The company also offers iodine-based and palladium-based implantable brachytherapy seeds for the treatment of prostate cancer. It provides a line of brachytherapy seeds for use in the treatment of ocular melanoma and other solid tumor applications. The company manufactures other radio isotopic products used in various medical, environmental, research and industrial applications. North American Scientific was incorporated in 1990 and is headquartered in Chatsworth, CA. | Electronic Technology |
TAE Life Sciences LLC
TAE Life Sciences LLC Pharmaceuticals: MajorHealth Technology TAE Life Sciences LLC is a privately-held biotechnology company that is developing a new biologically-targeted radiation therapy based on boron neutron capture therapy (BNCT). The company is based in Foothill Ranch, CA. The company is committed to developing next-generation targeted boron drugs and a low-energy accelerator-based neutron source that can treat patients with the most aggressive and recurrent cancers. TAE Life Sciences' Alphabeam™ neutron system and targeted boron drugs are currently in development and have not been approved for sale. Robert W. Hill has been the CEO of the company since 2019. | Health Technology |
- Borsa valori
- Insiders
- Robert Hill